Synthesis and biological activity evaluation of a novel pleuromutilin derivative 22-((2-methyl-1-(1H-pyrrole-2-carboxamido)propan-2-yl)thio)-deoxypleuromutilin.

Front Pharmacol · 2025 · PMC12447641 · PMID 40978463

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

One-way ANOVA with Dunnett’s post hoc testing was employed, with significance levels defined as p < 0.05 (significant) and p < 0.01 (highly significant).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.